Exc f/e/e/n/l mal+mrg 2.1-3
CPT 11643 covers surgical removal of a malignant (cancerous) skin lesion on the face, ears, eyelids, nose, or lips when the lesion measures 2.1 to 3.0 centimeters in diameter, including the margin removed around it.
This calculator gives a typical-case estimate using standard Medicare modifier rules. Actual payment depends on payer policies, documentation, code-specific CMS status indicators, and locality. Verify before billing.
RVU breakdown
Conversion factor: 32.3465 · Source: CMS MPFS RVU25A · Confidence: High
NCCI bundling edits
Loading bundling edits…
Billing tips
Measure and document the excised diameter (lesion plus margins) not the original lesion size, as this determines code selection within the 11640-11646 family
Impact: Incorrect measurement can result in downcoding from 11643 to 11642 ($252.48 non-facility) or upcoding scrutiny if using 11644 ($412.28), representing $54.49-$105.31 per claim
Bill in the non-facility setting when performed in office to capture the full $306.97 rate versus $221.90 facility rate
Impact: Setting selection yields $85.07 (27.7%) higher reimbursement per procedure when performed in physician office
When performing multiple excisions, list the most complex or highest RVU procedure first without modifier 51, then append 51 or 59 to subsequent procedures to minimize payment reduction
Impact: Strategic sequencing prevents 50% reduction on higher-value codes; can preserve $100+ per claim when billing multiple lesions
Document pathology confirmation of malignancy and ensure diagnosis codes specify malignant neoplasm of specific facial site (C44.x codes) to support medical necessity
Impact: Prevents denials for lack of medical necessity; benign lesion codes will trigger automatic denials requiring refund or appeal
Do not separately bill for simple closure as it is included in the excision code; only bill complex repair (13100-13153) if performed and documented
Impact: Prevents unbundling denials while ensuring capture of additional $200-500 when intermediate or complex closure is legitimately performed
For planned staged re-excision after pathology shows positive margins, use modifier 58 and link to original pathology report to demonstrate medical necessity
Real billers contribute denial patterns and appeal strategies for this code. Once 5+ reports come in, you’ll see live aggregated data here — the only place this exists, free.
Get the free Revenue Protection Toolkit — the denial triggers, modifier pitfalls, and bundling conflicts that quietly cost you reimbursement. Instant download.
Help build the field knowledge
MedPayIQ gets smarter as billers contribute. If you've had this code denied, share what happened so others learn from it. Anonymous, no patient info.